Ignite Creation Date:
2025-12-25 @ 5:06 AM
Ignite Modification Date:
2026-03-24 @ 4:51 PM
Study NCT ID:
NCT02651727
Status:
TERMINATED
Last Update Posted:
2017-07-27
First Post:
2016-01-06
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Ph 1 Study of VS-4718, a FAK Inhibitor, in Combination With Nab-paclitaxel and Gemcitabine in Advanced Cancer Subjects
Sponsor:
Verastem, Inc.
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
VS-4718-103
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None